Tetralogic Pharmaceuticals Corp Stock Total Debt
| TLOGDelisted Stock | USD 0.0001 0.00 0.00% |
TetraLogic Pharmaceuticals Corp fundamentals help investors to digest information that contributes to TetraLogic Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of TetraLogic Pink Sheet. The fundamental analysis module provides a way to measure TetraLogic Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TetraLogic Pharmaceuticals pink sheet.
TetraLogic |
TetraLogic Pharmaceuticals Corp Company Total Debt Analysis
TetraLogic Pharmaceuticals' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current TetraLogic Pharmaceuticals Total Debt | 28.33 M |
Most of TetraLogic Pharmaceuticals' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TetraLogic Pharmaceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, TetraLogic Pharmaceuticals Corp has a Total Debt of 28.33 M. This is 98.97% lower than that of the Biotechnology sector and 91.28% lower than that of the Health Care industry. The total debt for all United States stocks is 99.47% higher than that of the company.
TetraLogic Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TetraLogic Pharmaceuticals' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of TetraLogic Pharmaceuticals could also be used in its relative valuation, which is a method of valuing TetraLogic Pharmaceuticals by comparing valuation metrics of similar companies.TetraLogic Pharmaceuticals is currently under evaluation in total debt category among related companies.
TetraLogic Fundamentals
| Return On Asset | -0.2 | ||||
| Current Valuation | 458.72 K | ||||
| Shares Outstanding | 24.47 M | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 1.18 M | ||||
| Price To Earning | (0.03) X | ||||
| Price To Book | 0.40 X | ||||
| EBITDA | (43.15 M) | ||||
| Net Income | (49.72 M) | ||||
| Cash And Equivalents | 5.89 M | ||||
| Cash Per Share | 0.24 X | ||||
| Total Debt | 28.33 M | ||||
| Debt To Equity | 4.17 % | ||||
| Current Ratio | 0.48 X | ||||
| Book Value Per Share | (1.25) X | ||||
| Cash Flow From Operations | (34.89 M) | ||||
| Short Ratio | 4.39 X | ||||
| Earnings Per Share | (1.65) X | ||||
| Target Price | 1.0 | ||||
| Number Of Employees | 29 | ||||
| Beta | 3.0 | ||||
| Market Capitalization | 229.36 K | ||||
| Total Asset | 64.02 M | ||||
| Retained Earnings | (175.56 M) | ||||
| Working Capital | 18.31 M | ||||
| Current Asset | 21.97 M | ||||
| Current Liabilities | 3.66 M | ||||
| Z Score | -2.8 | ||||
| Net Asset | 64.02 M |
About TetraLogic Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TetraLogic Pharmaceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TetraLogic Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TetraLogic Pharmaceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in TetraLogic Pink Sheet
If you are still planning to invest in TetraLogic Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TetraLogic Pharmaceuticals' history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |